Aurinia Pharmaceuticals Inc.
AUPH
$15.37
$0.191.25%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 7.10% | 0.77% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.10% | 0.77% | |||
| Cost of Revenue | 30.91% | -65.54% | |||
| Gross Profit | 1.88% | 74.29% | |||
| SG&A Expenses | 6.71% | -24.70% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -2,334.41% | 101.89% | |||
| Total Operating Expenses | 1.64% | 6.17% | |||
| Operating Income | 11.88% | -3.53% | |||
| Income Before Tax | 11.07% | 23.07% | |||
| Income Tax Expenses | 18.83% | 105.47% | |||
| Earnings from Continuing Operations | 8.90% | -83.70% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 8.90% | -83.70% | |||
| EBIT | 11.88% | -3.53% | |||
| EBITDA | 10.68% | -3.27% | |||
| EPS Basic | 10.83% | -83.76% | |||
| Normalized Basic EPS | 13.02% | 22.65% | |||
| EPS Diluted | 12.00% | -83.61% | |||
| Normalized Diluted EPS | 14.44% | 23.53% | |||
| Average Basic Shares Outstanding | -1.73% | 0.33% | |||
| Average Diluted Shares Outstanding | -2.99% | -0.38% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||